Prevention of insulin-dependent diabetes mellitus: An overview of three trials

Cleveland Clinic Journal of Medicine

Volumn 63, Issue 5, 1996, Pages 270-274

  Schatz, Desmond A ^a,c   Rogers, Douglas G ^b   Brouhard, Ben H ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Box 100296 5HMHC ^*  (United States)

Author keywords

Autoimmunity; Insulin dependent diabetes mellitus; Prevention

Indexed keywords

CLINICAL TRIAL; GENETICS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK FACTOR;

CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; HUMANS; RISK FACTORS;

EID: 0030239325     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.63.5.270     Document Type: Article

References (24)

1. Diabetes Epidemiology Research International Group. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 1988; 37:1113-1119.
2. Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
3. Rubin RJ, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994; 78:809A-809F.
4. Ginsberg-Fellner F, Witt ME, Franklin BH, et al. Triad of markers for identifying children at high risk of developing insulin-dependent diabetes mellitus. JAMA 1985; 254:1469-1472.
5. Nell LJ, Arem R, Marshall RN, Rogers DG, Comstock JP, Ellenhorst JA, Thomas JW. Factors affecting the insulin autoantibody ELISA. Autoimmunity 1989; 2:299-309.
6. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes. N Engl J Med 1994; 331:1428-1436.
7. Muir A, Schatz DA, Maclaren NK. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus. Endocrinol Metab Clin North Am 1992; 21(2):199-219.
8. Maclaren N, Riley W, Skorids N, et al. Inherited susceptibility to insulin dependent diabetes is associated with HLA-DR1, while DR5 is protective. Autoimmunity 1988; 1:197-205.
9. Tosi G, Facchin A, Pinelli L, Accolla RS. Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM. Diabetes Care 1994; 17:1045-1048.
10. Owerbach D, Gunn S, Ty G, Wible L, Gabbay KH. Oligonucleotide probes for HLA-DQA and DQB genes define susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1988; 31:751-757.
11. Huang W, She J, Muir A, et al. High risk HLA-DR/DQ genotypes for IDD confer susceptibility to autoantibodies but DQB1*0602 does not prevent them. J Autoimmun 1994; 7:889-897.
12. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark A. HLA-DQ primarily confers protection and HLA-DR susceptibility in type 1 (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 1993; 53:150-167.
13. Bingley PJ, Christie MR, Bonifacio E, et al. Combined analyses of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43:1304-1310.
14. Gerstein HC. Cow's milk exposure and type 1 diabetes mellitus Diabetes Care 1994; 17:13-19.
15. Coleman DL, Kuzava JE, Leiter EH. Effect of diet on incidence of diabetes in nonobese diabetic mice. Diabetes 1990; 39:432-436.
16. Akerblom HK, Savilahti e, Saukkonen TT, et al. The case for elimination of cow's milk in early infancy in the prevention of type I diabetes, the Finnish experience Diabetes Metab Rev 1993 Dec; 9(4):269-278.
17. Atkinson M, Maclaren N, Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990; 39:933-937.
18. Gotfredsen CF, Buschard K, Frandsen EK. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals Diabetologia 1985; 28:933-935.
19. Zhang I, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88:10 252 - 10 256.
20. Weiner HL, Mackin GA, Matsui M, et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259:1321-1324.
21. Trentham DE, Dynesius-Trentham RA, Orav EJ et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261:1727-1730.
22. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type 1 diabetes Lancet 1993; 341:927-928.
23. Elliott RB, Pilcher CC, Stewart A, Fergusson D, McGregor MA. The use of nicotinamide in the prevention of type 1 diabetes. Ann NY Acad Sci 1993; 696:333-341.
24. Elliot RB, Chase HP. Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 1991; 34:362-365.